Target prediction for an open access set of compounds active against Mycobacterium tuberculosis.
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects an estimated two billion people worldwide and is the leading cause of mortality due to infectious disease. The development of new anti-TB therapeutics is required, because of the emergence of multi-drug resistance strains...
Guardado en:
Autores principales: | Francisco Martínez-Jiménez, George Papadatos, Lun Yang, Iain M Wallace, Vinod Kumar, Ursula Pieper, Andrej Sali, James R Brown, John P Overington, Marc A Marti-Renom |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/158c9ce621374bd5a95c3758e94eddb2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mycobacterium tuberculosis
por: Vecchiola H,Maggie
Publicado: (2010) -
Epidemiology of Mycobacterium tuberculosis lineages and strain clustering within urban and peri-urban settings in Ethiopia.
por: Hawult Taye, et al.
Publicado: (2021) -
MYCOBACTERIUM TUBERCULOSIS VIRULENCE
por: B. I. Vishnevskiy, et al.
Publicado: (2015) -
Tuberculosis outcomes related to the Mycobacterium tuberculosis genotype
por: O. A. Pasechnik, et al.
Publicado: (2019) -
An open-access and inexpensive 3D printed otoscope for low-resource settings and health crises
por: Matteo Capobussi, et al.
Publicado: (2021)